These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 21892163)

  • 1. Nanopore-based detection of circulating microRNAs in lung cancer patients.
    Wang Y; Zheng D; Tan Q; Wang MX; Gu LQ
    Nat Nanotechnol; 2011 Sep; 6(10):668-74. PubMed ID: 21892163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanopore single-molecule detection of circulating microRNAs.
    Gu LQ; Wang Y
    Methods Mol Biol; 2013; 1024():255-68. PubMed ID: 23719958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Circulating microRNAs in lung cancer: prospects for diagnostics, prognosis and prediction of antitumor treatment efficiency].
    Vlasov VV; Rykova EIu; Ponomareva AA; Zaporozhchenko IA; Morozkin ES; Cherdyntseva NV; Laktionov PP
    Mol Biol (Mosk); 2015; 49(1):55-66. PubMed ID: 25916110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanopore-Based Selective Discrimination of MicroRNAs with Single-Nucleotide Difference Using Locked Nucleic Acid-Modified Probes.
    Xi D; Shang J; Fan E; You J; Zhang S; Wang H
    Anal Chem; 2016 Nov; 88(21):10540-10546. PubMed ID: 27734673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating MicroRNAs as Potential Biomarkers for Lung Cancer.
    Müller S; Janke F; Dietz S; Sültmann H
    Recent Results Cancer Res; 2020; 215():299-318. PubMed ID: 31605236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portable and Field-Ready Detection of Circulating MicroRNAs with Paper-Based Bioluminescent Sensing and Isothermal Amplification.
    Li Y; Zhou L; Ni W; Luo Q; Zhu C; Wu Y
    Anal Chem; 2019 Dec; 91(23):14838-14841. PubMed ID: 31693337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intelligent identification of multi-level nanopore signatures for accurate detection of cancer biomarkers.
    Zhang JH; Liu XL; Hu ZL; Ying YL; Long YT
    Chem Commun (Camb); 2017 Sep; 53(73):10176-10179. PubMed ID: 28852755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing a polycationic probe for simultaneous enrichment and detection of microRNAs in a nanopore.
    Tian K; He Z; Wang Y; Chen SJ; Gu LQ
    ACS Nano; 2013 May; 7(5):3962-9. PubMed ID: 23550815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-based Biomarkers for Early Diagnosis of Lung Cancer: A Review Article.
    Maharjan N; Thapa N; Tu J
    JNMA J Nepal Med Assoc; 2020 Jul; 58(227):519-524. PubMed ID: 32827019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole blood microRNA expression may not be useful for screening non-small cell lung cancer.
    Patnaik SK; Kannisto ED; Mallick R; Vachani A; Yendamuri S
    PLoS One; 2017; 12(7):e0181926. PubMed ID: 28742859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA expression profiles of whole blood in lung adenocarcinoma.
    Patnaik SK; Yendamuri S; Kannisto E; Kucharczuk JC; Singhal S; Vachani A
    PLoS One; 2012; 7(9):e46045. PubMed ID: 23029380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid electronic detection of probe-specific microRNAs using thin nanopore sensors.
    Wanunu M; Dadosh T; Ray V; Jin J; McReynolds L; Drndić M
    Nat Nanotechnol; 2010 Nov; 5(11):807-14. PubMed ID: 20972437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of microarrays: diagnostic value of microRNA-21 as a biomarker for lung cancer.
    Meng X; Xiao C; Zhao Y; Jia L; Tang Y; Li D
    Int J Biol Markers; 2015 Jul; 30(3):e282-5. PubMed ID: 26109362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Non-coding RNA as Biomarkers in Colorectal Cancer.
    Ferracin M; Lupini L; Mangolini A; Negrini M
    Adv Exp Med Biol; 2016; 937():171-81. PubMed ID: 27573900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.
    Tang D; Shen Y; Wang M; Yang R; Wang Z; Sui A; Jiao W; Wang Y
    Eur J Cancer Prev; 2013 Nov; 22(6):540-8. PubMed ID: 23462458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microfluidic device for novel breast cancer screening by blood test using miRNA beacon probe.
    Salim B; Athira MV; Kandaswamy A; Vijayakumar M; Saravanan T; Sairam T
    Biomed Microdevices; 2017 Sep; 19(4):89. PubMed ID: 28965149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of miRNAs with a nanopore single-molecule counter.
    Gu LQ; Wanunu M; Wang MX; McReynolds L; Wang Y
    Expert Rev Mol Diagn; 2012 Jul; 12(6):573-84. PubMed ID: 22845478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential circulating miRNA signature for early detection of NSCLC.
    Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
    Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer.
    Hetta HF; Zahran AM; Shafik EA; El-Mahdy RI; Mohamed NA; Nabil EE; Esmaeel HM; Alkady OA; Elkady A; Mohareb DA; Hosni A; Mostafa MM; Elkady A
    Microrna; 2019; 8(3):206-215. PubMed ID: 30652656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.